Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Arcturus Therapeutics Holdings (ARCT) Shares Outstanding (2018 - 2025)

Historic Shares Outstanding for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to $27.2 million.

  • Arcturus Therapeutics Holdings' Shares Outstanding rose 55.75% to $27.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.2 million, marking a year-over-year increase of 55.75%. This contributed to the annual value of $27.1 million for FY2024, which is 99.9% up from last year.
  • According to the latest figures from Q3 2025, Arcturus Therapeutics Holdings' Shares Outstanding is $27.2 million, which was up 55.75% from $27.1 million recorded in Q2 2025.
  • Arcturus Therapeutics Holdings' Shares Outstanding's 5-year high stood at $27.2 million during Q3 2025, with a 5-year trough of $26319.0 in Q1 2021.
  • Moreover, its 5-year median value for Shares Outstanding was $26.6 million (2023), whereas its average is $22.6 million.
  • As far as peak fluctuations go, Arcturus Therapeutics Holdings' Shares Outstanding plummeted by 9989.23% in 2021, and later soared by 10044271.51% in 2022.
  • Arcturus Therapeutics Holdings' Shares Outstanding (Quarter) stood at $26.4 million in 2021, then increased by 0.69% to $26.6 million in 2022, then grew by 1.03% to $26.8 million in 2023, then rose by 1.0% to $27.1 million in 2024, then increased by 0.51% to $27.2 million in 2025.
  • Its Shares Outstanding stands at $27.2 million for Q3 2025, versus $27.1 million for Q2 2025 and $27.1 million for Q1 2025.